New COVID-19 nasal spray outperforms current antibody treatments in mice?
The Pharma Data
APRIL 15, 2022
When researchers administered the treatment to mice as a nasal spray, they found that the best of these antiviral proteins reduced symptoms of infection – or even prevented infection outright. The findings were published yesterday (April 12) in the journal Science Translational Medicine. Food and Drug Administration (FDA).
Let's personalize your content